Timely Updates in the Treatment of Waldenstrom's Macroglobulinemia-Zanubrutinib 

In this presentation, Dr. Steve Treon of the Bing Center for Waldenstrom’s Macroglobulinemia presents timely updates in the treatment of WM with a focus on the newly FDA approved Zanubrutinib.